Guren MG - Search Results

1

Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer.

Bergsland CH, Bruun J, Guren MG, Svindland A, Bjørnslett M, Smeby J, Hektoen M, Kolberg M, Domingo E, Pellinen T, Tomlinson I, Kerr D, Church DN, Nesbakken A, Sveen A, Lothe RA. Bergsland CH, et al. Among authors: guren mg. ESMO Open. 2020 Nov;5(6):e001040. doi: 10.1136/esmoopen-2020-001040. ESMO Open. 2020. PMID: 33219056 Free PMC article.

2

International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire.

Sodergren SC, Johnson CD, Gilbert A, Darlington AS, Cocks K, Guren MG, Rivin Del Campo E, Brannan C, Christensen P, Chu W, Chung H, Dennis K, Desideri I, Gilbert DC, Glynne-Jones R, Jefford M, Johansson M, Johnsson A, Juul T, Kardamakis D, Lai-Kwon J, McFarlane V, Miguel IMC, Nugent K, Peters F, Riechelmann RP, Turhal NS, Wong S, Vassiliou V; European Organisation for Research and Treatment of Cancer Quality of Life Group. Sodergren SC, et al. Among authors: guren mg. Int J Radiat Oncol Biol Phys. 2023 Apr 1;115(5):1155-1164. doi: 10.1016/j.ijrobp.2022.11.002. Epub 2022 Nov 17. Int J Radiat Oncol Biol Phys. 2023. PMID: 36402360

3

Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer.

Guren MG, Eriksen MT, Wiig JN, Carlsen E, Nesbakken A, Sigurdsson HK, Wibe A, Tveit KM; Norwegian Rectal Cancer Group. Guren MG, et al. Eur J Surg Oncol. 2005 Sep;31(7):735-42. doi: 10.1016/j.ejso.2005.05.004. Eur J Surg Oncol. 2005. PMID: 16180267

4

Anticipating the clinical use of prognostic gene expression-based tests for colon cancer stage II and III: is Godot finally arriving?

Sveen A, Nesbakken A, Ågesen TH, Guren MG, Tveit KM, Skotheim RI, Lothe RA. Sveen A, et al. Among authors: guren mg. Clin Cancer Res. 2013 Dec 15;19(24):6669-77. doi: 10.1158/1078-0432.CCR-13-1769. Epub 2013 Oct 28. Clin Cancer Res. 2013. PMID: 24166914

5

Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010.

Guren MG, Kørner H, Pfeffer F, Myklebust TÅ, Eriksen MT, Edna TH, Larsen SG, Knudsen KO, Nesbakken A, Wasmuth HH, Vonen B, Hofsli E, Færden AE, Brændengen M, Dahl O, Steigen SE, Johansen MJ, Lindsetmo RO, Drolsum A, Tollåli G, Dørum LM, Møller B, Wibe A. Guren MG, et al. Acta Oncol. 2015 Nov;54(10):1714-22. doi: 10.3109/0284186X.2015.1034876. Epub 2015 Apr 30. Acta Oncol. 2015. PMID: 25924970

6

Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival.

Labori KJ, Guren MG, Brudvik KW, Røsok BI, Waage A, Nesbakken A, Larsen S, Dueland S, Edwin B, Bjørnbeth BA. Labori KJ, et al. Among authors: guren mg. Colorectal Dis. 2017 Aug;19(8):731-738. doi: 10.1111/codi.13622. Colorectal Dis. 2017. PMID: 28181384

7

Preoperative chemoradiotherapy for rectal cancer and impact on outcomes - A population-based study.

Åsli LM, Johannesen TB, Myklebust TÅ, Møller B, Eriksen MT, Guren MG. Åsli LM, et al. Among authors: guren mg. Radiother Oncol. 2017 Jun;123(3):446-453. doi: 10.1016/j.radonc.2017.04.012. Epub 2017 May 5. Radiother Oncol. 2017. PMID: 28483302

8

CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer.

Smeby J, Sveen A, Merok MA, Danielsen SA, Eilertsen IA, Guren MG, Dienstmann R, Nesbakken A, Lothe RA. Smeby J, et al. Among authors: guren mg. Ann Oncol. 2018 May 1;29(5):1227-1234. doi: 10.1093/annonc/mdy085. Ann Oncol. 2018. PMID: 29518181 Free PMC article.

9

Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer.

Bruun J, Sveen A, Barros R, Eide PW, Eilertsen I, Kolberg M, Pellinen T, David L, Svindland A, Kallioniemi O, Guren MG, Nesbakken A, Almeida R, Lothe RA. Bruun J, et al. Among authors: guren mg. Mol Oncol. 2018 Sep;12(9):1639-1655. doi: 10.1002/1878-0261.12347. Epub 2018 Aug 15. Mol Oncol. 2018. PMID: 29900672 Free PMC article.

10

Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer.

Smeby J, Sveen A, Eilertsen IA, Danielsen SA, Hoff AM, Eide PW, Johannessen B, Hektoen M, Skotheim RI, Guren MG, Nesbakken A, Lothe RA. Smeby J, et al. Among authors: guren mg. Oncogenesis. 2019 May 15;8(6):35. doi: 10.1038/s41389-019-0141-3. Oncogenesis. 2019. PMID: 31092812 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page